Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
42.52%
↑ 131% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-136.27%
Historical baseline
PeriodValue
202542.52%
202414.97%
2023-118.86%
2022-349.06%
202148.43%
2020-474.11%
2019-254.06%
20180.00%